Abstract 2020: Fibroblast derived type III collagen pro-peptides (PRO-C3) in plasma is associated with outcome for patients with NSCLC treated with anti-PD1 plus chemotherapy
Authors: Nicholas Willumsen, Lola Lecru, Thibaut Brugat, John Stagg, Bertrand Routy, Morten A. Karsdal